Negative symptoms in youths with psychosis spectrum features: Complementary scales in relation to neurocognitive performance and function

Schizophrenia Research

Volumn 166, Issue 1-3, 2015, Pages 322-327

  Gur, Raquel E ^a   March, Mary ^a   Calkins, Monica E ^a   Weittenhiller, Lauren ^a   Wolf, Daniel H ^a   Turetsky, Bruce I ^a   Gur, Ruben C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Clinical risk; Negative symptoms; Neurocognition; Psychosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT INTERVIEW FOR NEGATIVE SYMPTOMS; COGNITION; CONTROLLED STUDY; GLOBAL ASSESSMENT OF FUNCTIONING; HIGH RISK POPULATION; HUMAN; MENTAL DISEASE ASSESSMENT; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; PENN COMPUTERIZED NEUROCOGNITIVE BATTERY; PRIORITY JOURNAL; PSYCHOSIS; STRUCTURED INTERVIEW FOR PRODROMAL SYNDROMES; FEMALE; MALE; PRODROMAL SYMPTOM; PSYCHOLOGICAL INTERVIEW; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RISK; SCHIZOPHRENIA; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; NEUROPSYCHOLOGICAL TESTS; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84946485077     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.05.037     Document Type: Article

References (42)

1. Adolphs R., Anderson D. Social and emotional neuroscience. Curr. Opin. Neurobiol. 2013, 23(3):291-293.
2. Allott K.A., Schäfer M.R., Thompson A., Nelson B., Bendall S., Bartholomeusz C.F., Yuen H.P., McGorry P.D., Schlögelhofer M., Bechdolf A., Amminger G.P. Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants. Schizophr. Res. 2014, 153(1-3):25-31.
3. Amminger G.P., Schäfer M.R., Papageorgiou K., Klier C.M., Schlögelhofer M., Mossaheb N., Werneck-Rohrer S., Nelson B., McGorry P.D. Emotion recognition in individuals at clinical high-risk for schizophrenia. Schizophr. Bull. 2012, 38(5):1030-1039.
4. Andreasen N. The Scale for the Assessment of Negative Symptoms (SANS) 1983, University of Iowa, Iowa City, IA.
5. Cacioppo J.T., Cacioppo S., Dulawa S., Palmer A.A. Social neuroscience and its potential contribution to psychiatry. World Psychiatry 2014, 13(2):131-139.
6. Calkins M.E., Tepper P., Gur R.C., Ragland J.D., Klei L., Wiener H.W., Richard J., Savage R.M., Allen T.B., O'Jile J., Devlin B., Kwentus J., Aliyu M.H., Bradford L.D., Edwards N., Lyons P.D., Nimgaonkar V.L., Santos A.B., Go R.C., Gur R.E. Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients. Am. J. Psychiatry 2010, 167(4):459-472.
7. Calkins M.E., Ray A., Gur R.C., Freedman R., Green M.F., Greenwood T.A., Light G.A., Nuechterlein K.H., Olincy A., Radant A.D., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Sugar C., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., BraffD.L., Lazzeroni L.C., Gur R.E. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biol. Psychiatry 2013, 73(10):976-984.
8. Calkins M.E., Moore T.M., Merikangas K.R., Burstein M., Satterthwaite T.D., Bilker W.B., Ruparel K., Chiavacci R., Wolf D.H., Mentch F., Qiu H., Connolly J.J., Sleiman P.A., Hakonarson H., Gur R.C., Gur R.E. The psychosis spectrum in a young U.S. community sample: findings from the Philadelphia Neurodevelopmental Cohort. World Psychiatry 2014, 13(3):296-305.
9. Cornblatt B.A., Carrión R.E., Addington J., Seidman L., Walker E.F., Cannon T.D., Cadenhead K.S., McGlashan T.H., Perkins D.O., Tsuang M.T., Woods S.W., Heinssen R., Lencz T. Risk factors for psychosis: impaired social and role functioning. Schizophr. Bull. 2012, 38(6):1247-1257.
10. Demjaha A., Valmaggia L., Stahl D., Byrne M., McGuire P. Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr. Bull. 2012, 38(2):351-359.
11. Erhart S.M., Marder S.R., Carpenter W.T. Treatment of schizophrenia negative symptoms: future prospects. Schizophr. Bull. 2006, 32(2):234-237.
12. Gur R.E., Kohler C.G., Ragland J.D., Siegel S.J., Lesko K., Bilker W.B., Gur R.C. Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. Schizophr. Bull. 2006, 32(2):279-287.
13. Gur R.E., Loughead J., Kohler C.G., Elliott M.A., Lesko K., Ruparel K., Wolf D.H., Bilker W.B., Gur R.C. Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia. Arch. Gen. Psychiatry 2007, 64(12):1356-1366.
14. Gur R.E., Nimgaonkar V.L., Almasy L., Calkins M.E., Ragland J.D., Pogue-Geile M.F., Kanes S., Blangero J., Gur R.C. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am. J. Psychiatry 2007, 164(5):813-819.
15. Gur R.C., Richard J., Hughett P., Calkins M.E., Macy L., Bilker W.B., Brensinger C., Gur R.E. A cognitive neuroscience-based computerized battery for efficient measurement of individual differences: standardization and initial construct validation. J. Neurosci. Methods 2010, 187(2):254-262.
16. Gur R.C., Richard J., Calkins M.E., Chiavacci R., Hansen J.A., Bilker W.B., Loughead J., Connolly J.J., Qiu H., Mentch F.D., Abou-Sleiman P.M., Hakonarson H., Gur R.E. Age group and sex differences in performance on a computerized neurocognitive battery in children age 8-21. Neuropsychology 2012, 26(2):251-265.
17. Gur R.C., Calkins M.E., Satterthwaite T.D., Ruparel K., Bilker W.B., Moore T.M., Savitt A.P., Hakonarson H., Gur R.E. Neurocognitive growth charting in psychosis spectrum youths. JAMA Psychiatry 2014, 71(4):366-374.
18. Gur R.C., BraffD.L., Calkins M.E., Dobie D.J., Freedman R., Green M.F., Greenwood T.A., Lazzeronia L.C., Light G.A., Nuechterlein K.H., Olincy A., Radant A.D., Seidman L.J., Siever L.J., Silverman J.M., Sprock J., Stone W.S., Sugar C.A., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Gur R.E. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophr. Res. 2015, 163(1-3):17-23.
19. Irani F., Seligman S., Kamath V., Kohler C., Gur R.C. A meta-analysis of emotion perception and functional outcomes in schizophrenia. Schizophr. Res. 2012, 137(1-3):203-211.
20. Johnstone E.C., Ebmeier K.P., Miller P., Owens D.G., Lawrie S.M. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br. J. Psychiatry 2005, 186:18-25.
21. Kahn R.S., Keefe R.S. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry 2013, 70(10):1107-1112.
22. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., Williamson D., Ryan N. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psychiatry 1997, 36(7):980-988.
23. Kay S.R., Flszbein A., Opfer L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
24. Kohler C.G., Richard J.A., Brensinger C.M., Borgmann-Winter K.E., Conroy C.G., Moberg P.J., Gur R.C., Gur R.E., Calkins M.E. Facial emotion perception differs in young persons at genetic and clinical high-risk for psychosis. Psychiatry Res. 2014, 216(2):206-212.
25. Kring A.M., Gur R.E., Blanchard J.J., Horan W.P., Reise S.P. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am. J. Psychiatry 2013, 170(2):165-172.
26. Kwapil T.R., Gross G.M., Silvia P.J., Barrantes-Videl N. Prediction of psychopathology and functional impairment by positive and negative schizotypy in the Chapmans' ten-year longitudinal study. J. Abnorm. Psychol. 2013, 122(3):807-815.
27. Lyne J., Renwick L., Madigan K., O'Donoghue B., Bonar M., Grant T., Kinsella A., Malone K., Turner N., O'Callaghan E., Clarke M. Do psychosis prodrome onset negative symptoms predict first presentation negative symptoms?. Eur. Psychiatry 2014, 29(3):153-159.
28. Mason O., Startup M., Halpin S., Schall U., Conrad A., Carr V. Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophr. Res. 2004, 71(2-3):227-237.
29. Maxwell M.E. Manual for the FIGS 1992, National Institute of Mental Health, Bethesda, MD.
30. McGlashan T.H., Miller T.J., Woods S.W., Rosen J.L., Hoffman R.E., Davidson L. Structured Interview for Prodromal Syndromes (Version 4.0) Prime Clinic Yale School of Medicine, New Haven, CT 2003, Prime Clinic Yale School of Medicine, New Haven.
31. Meyer E.C., Carrión R.E., Cornblatt B.A., Addington J., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R., Seidman L.J. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal study. Schizophr. Bull. 2014, 40(6):1452-1461.
32. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Cannon T., Ventura J., McFarlane W., Perkins D.O., Pearlson G.D., Woods S.W. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 2003, 29(4):703-715.
33. Murphy B.P., Stuart A.H., McGorry P.D. Duration of untreated negative symptoms and duration of active negative symptoms: proof of concepts. Early Interv. Psychiatry 2008, 2:27-33.
34. Nieman D.H., Velthorst E., Becker H.E., de Haan L., Dingemans P.M., Linszen D.H., et al. The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis. Acta Psychiatr. Scand. 2013, 127:53-61.
35. Piskulic D., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., McGlashan T.H. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res. 2012, 196(2-3):220-224.
36. Schultze-Lutter F., Ruhrmann S., Berning J., Maier W., Klosterkötter J. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr. Bull. 2010, 36(1):182-191.
37. Schultze-Lutter F., Ruhrmann S., Fusar-Poli P., Bechdolf A., Schimmelmann B.G., Klosterkötter J. Basic symptoms and the prediction of first-episode psychosis. Curr. Pharm. Des. 2012, 18(4):351-357.
38. Walther S., Stegmayer K., Sulzbacher J., Vanbellingen T., Müri R., Strik W., Bohlhalter S. Nonverbal social communication and gesture control in schizophrenia. Schizophr. Bull. 2015, 41(2):338-345.
39. Wilkinson G.S., Robertson G.J. Psychological Assessment Resources. Wide Range Achievement Test 2006, WRAT4 Introductory Kit. Fourth edition. F.L. Lutz (Ed.).
40. Wolf D.H., Satterthwaite T.D., Kantrowitz J.J., Katchmar N., Vandekar L., Elliott M.A., Ruperal K. Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. Schizophr. Bull. 2014, 40(6):1328-1337.
41. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 2004, 67:131-142.
42. Yung A.R., Nelson B., Stanford C., Simmons M.B., Cosgrave E.M., Killackey E., et al. Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2year follow-up. Schizophr. Res. 2008, 105:10-17.